Are atherogenic lipoproteins responsible for the association between⬆️TG/HDL ratio and CVD? Martina Chiriacò Lorenzo Nesti and @DomenTric shed light on the topic at #EASD22 EASD

The brilliant Lorenzo Nesti explains how empagliflozin improves LV contractility in patients with subclinical dysfunction in the EMPA-HEART trial #EASD22 EASD Read the full article here ➡️doi.org/10.1186/s12933… Springer Nature BMC

Fat is bad for the heart too! See how epicardial adipose tissue affects cardiopulmonary performance in type 2 diabetes. A great paper by Lorenzo Nesti #diabetes #CardioTwitter #cardiovasculardisease doi.org/10.1111/dom.14… ↘️

Blood pressure rising at night more than doubles the mortality risk in type 2 diabetes, results from a 21-year follow-up. Out now on DOM! ➡️ doi.org/10.1111/dom.14… by Martina Chiriacò Luca Sacchetta Lorenzo Nesti @DomenTric #diabetes #cardiovascular #hypertension

Lorenzo Nesti vincitore del premio Umberto Di Mario 2022 con lo studio "Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes" ➡️ doi:10.1186/s12933-021-01314-6 SID Italia YoSID #diabetes

It's a wrap! 29° Congresso SID Italia pieno di soddisfazioni e nuove idee! See you next year #siditalia

Glomerular hyperfiltration in #diabetes: increases risk of worsening kidney function and CV or renal death. Don't overlook it! Check out our results Diabetes Care, an ADA research journal 🌟 doi.org/10.2337/dc22-2…

Tanti spunti da Panorama Diabete e tante soddisfazioni per i nostri giovani ricercatori Luca Sacchetta premio Umberto Di Mario e Lorenzo Nesti premio Galeno 🏆🏆🏆 SID Italia

Go beyond the same old interpretation of TG and HDLc levels: see how size and concentration of different lipoproteins change with increasing TG/HDL ratio ↗️ Spoiler: it gets worse doi.org/10.1002/oby.23… The Obesity Society Martina Chiriacò @DomenTric Lorenzo Nesti

Who cares about leptin? We do! Not one but two presentations at #EASD2023 EASD by Martina Chiriacò and Luca Sacchetta on why high leptin may be bad news even if you are lean

Lorenzo Nesti shows how diabetes and obesity affects cardiopulmonary fitness at #EASD2023 EASD

Distinct effects of type 2 diabetes and obesity on cardiopulmonary performance. 💡Our last paper on #DOM Wiley in research Università di Pisa Ricerca UNIPI AOUP / Azienda ospedaliero-universitaria pisana 🩺 Editors: META Lab_Unipi Lorenzo Nesti Nicola Riccardo #obesity #diabetes #CPET 🔗…ubs.pericles-prod.literatumonline.com/doi/10.1111/do…

Partners in crime: #diabetes and #obesity work separately to worsen cardiopulmonary performance 🫀 New paper by Lorenzo Nesti and HFLabUnipi ⬇️ doi.org/10.1111/dom.15…

Dr. Lorenzo Nesti answers the question "Is metabolic flexibility relevant for the heart and exercise?" during the second day of the national congress of the Italian Diabetes Society. SID Italia Lorenzo Nesti

Dr. Lorenza Santoni presented thr "Effects of empagliflozin vs sitagliptin on exercise macronutrient oxidation rates in type 2 diabetes" during the annual congress of the Italian Society of Diabetologia Lorenza Santoni SID Italia

Our Cardiopulmonary Exercise Testing Queen 👑 dr. Lorenza Santoni presenting her work at 61th EASD Annual Meeting in Vienna.

We have a Queen, but also a C-PET King! 👑 Dr. Lorenzo Nesti presented the results of his work on #HFpEF at 61th EASD Annual Meeting in Vienna.